Rituxan (rituximab) - Roche
Recurrent Intermittent Small Bowel Obstruction as an Initial Manifestation of Primary Intestinal Diffuse Large B-Cell Lymphoma: A Case Report and Systematic Literature Review. (PubMed, Case Rep Surg) - Oct 16, 2026 - "Histopathological examination confirmed CD10-positive DLBCL, and systemic treatment with six cycles of R-CHOP was initiated...Recurrent SBO in a patient without previous abdominal surgery, particularly when serial imaging demonstrates evolving mesenteric or intestinal abnormalities, should prompt renewed investigation for an underlying malignancy, including intestinal lymphoma. Repeat cross-sectional imaging, multidisciplinary reassessment, and individualized consideration of operative exploration may facilitate timely diagnosis while avoiding conclusions that transient improvement represents definitive resolution." 
Journal • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Neuroendocrine Tumor • Non-Hodgkin's Lymphoma • Oncology • Pain • Small Intestinal Carcinoma • Solid Tumor • MME
http://www.ncbi.nlm.nih.gov/pubmed/42877641
 
Ann-Catrin Ekelund; Jenny Nyqvist-Streng; Karl Nilsson Grip; Marcus Gustavsson; Olof Söderman
 
Oct 16, 2026
 
Prev Next